Chemoinformaics analysis of -Methyl-4-(prop-1-en-2-yl)benzene
| Molecular Weight | 132.206 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
| Exact Molecular Weight | 132.094 | nRing | 1 |
| Solubility: LogS | -4.128 | nHRing | 0 |
| Solubility: LogP | 3.904 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 24.7015 |
| nHD | 0 | BPOL | 12.0385 |
| QED | 0.551 |
| Synth | 1.633 |
| Natural Product Likeliness | -0.016 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.344 |
| MDCK | 0.0000244 |
| BBB | 0.891 |
| PPB | 0.850011 |
| VDSS | 1.453 |
| FU | 0.184758 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.929 |
| CYP2c19-inh | 0.848 |
| CYP2c19-sub | 0.708 |
| CYP2c9-inh | 0.488 |
| CYP2c9-sub | 0.799 |
| CYP2d6-inh | 0.042 |
| CYP2d6-sub | 0.783 |
| CYP3a4-inh | 0.079 |
| CYP3a4-sub | 0.407 |
| CL | 10.755 |
| T12 | 0.568 |
| hERG | 0.071 |
| Ames | 0.068 |
| ROA | 0.095 |
| SkinSen | 0.818 |
| Carcinogencity | 0.497 |
| EI | 0.991 |
| Respiratory | 0.052 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.913835 |